Sr Director Marketing, External Engagement--HIV Prevention
Gilead Sciences
Summary
You will be an integral part of a fast paced highly collaborative team, who are on a mission to increase awareness, knowledge, relevancy, and usage of PrEP as part of preventative health for all who could benefit from it.
Job description
Key Responsibilities
- Must possess a demonstrated ability to define and lead the external engagement strategy and multi-dimensional marketing plan aligned to U.S. HIV prevention brand goals
- Build demand and credibility for Gilead PrEP products through meaningful engagement with thought leaders, experts, and organizations across diverse HCP audiences who prescribe [or should consider prescribing] PrEP
- Effectively direct and oversee multiple projects and priorities like: peer‑to‑peer programs, speaker bureaus, advisory boards, congress activities, and educational initiatives
- Empower team to translate scientific, clinical, and market insights into clear objectives and compelling HCP‑focused content
- Identify, develop, and manage strategic partnerships with external experts and organizations to support short term and long term brand strategies
- Monitor the evolving HIV prevention landscape and proactively identify areas of strategic opportunity
- Lead cross‑functional collaboration with Medical, Legal, Regulatory, Compliance, Sales, Analytics, and Marketing teams
- Define KPIs, measure performance, and optimize programs based on data and insights
- Manage agency partners, vendors, and multiple marketing budgets to ensure on‑time, on‑budget delivery
- Ensure all activities meet regulatory, legal, and internal compliance standards
- Establish and maintain relationships with key opinion leaders, key accounts, and medical associations
- Evaluate and evolve current approaches and systems (as needed)
- Design and deliver presentations to a range of internal stakeholders and external audiences
- Expert command and demonstrated track record of pharmaceutical communications [branded, unbranded, non-branded, administrative, etc] across traditional and non-traditional channels
- Contribute to annual local strategic plan and lead team in tactical planning aligned with brand objectives and educational priorities
Leadership & People Management
- Set vision and operating rhythm for the external engagement team
- Coach, develop, and retain high‑performing talent
- Foster inclusion, accountability, and collaboration across teams
- Lead change and continuously improve processes for scale and impact
Basic Qualifications
14+ Years with BS/BA OR 12+ Years with MS/MA or MBA
Preferred Qualifications
- Bachelor’s degree with 12+ years of experience; advanced degree (MBA, MS, PhD) preferred
- 10+ years of pharmaceutical or biotech marketing experience, preferably in preventative categories and/or with injectable products
- Proven ability to work well as part of a team
- Strong desire and ability to work in a fast-paced and dynamic environment
- Demonstrated ability to translate complex science into clear, compliant marketing strategies
- Proven track record of cross‑functional leadership and external partnership development
- Expert understanding of pharmaceutical regulatory requirements and impact on development of marketing materials is required
- Comfortable discussing topics relevant to the HIV prevention space, including sexual health, mental health, and substance use. HIV or HIV adjacent experience is a plus.
- Experience managing and collaborating with agency partners is a must
- Strong communications skills and attention to detail; written, spoken, in presentations, etc.
- A track record of building new and maintaining partnerships, collaborating with strong influence & negotiation skills are required
- Strong project management skills and demonstrated ability to successfully execute complex initiatives
- Launch experience and portfolio management preferred
- Ability to travel up to 30%
Requirements
- 14+ Years with BS/BA OR 12+ Years with MS/MA or MBA
- Bachelor’s degree with 12+ years of experience; advanced degree (MBA, MS, PhD) preferred
- 10+ years of pharmaceutical or biotech marketing experience, preferably in preventative categories and/or with injectable products
- Proven ability to work well as part of a team
- Strong desire and ability to work in a fast-paced and dynamic environment
- Demonstrated ability to translate complex science into clear, compliant marketing strategies
- Proven track record of cross‑functional leadership and external partnership development
- Expert understanding of pharmaceutical regulatory requirements and impact on development of marketing materials is required
- Comfortable discussing topics relevant to the HIV prevention space, including sexual health, mental health, and substance use. HIV or HIV adjacent experience is a plus.
- Experience managing and collaborating with agency partners is a must
- Strong communications skills and attention to detail; written, spoken, in presentations, etc.
- A track record of building new and maintaining partnerships, collaborating with strong influence & negotiation skills are required
- Strong project management skills and demonstrated ability to successfully execute complex initiatives
- Launch experience and portfolio management preferred
- Ability to travel up to 30%
Benefits
- Medical, Dental & Vision
- Life Insurance
- Paid Time Off
- Annual Bonus
- Stock-based Long-term Incentives
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.